• Innohep (tinzaparin) is a blood thinner ( anticoagulant ) used together with warfarin ( Coumadin ) to treat a type of blood clot called deep vein thrombosis , or DVT. (rxlist.com)
  • Our Innohep (tinzaparin) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication. (rxlist.com)
  • INNOHEP® is a sterile solution, containing tinzaparin sodium, a low molecular weight heparin . (rxlist.com)
  • INNOHEP® (tinzaparin) is indicated for the treatment of acute symptomatic deep vein thrombosis with or without pulmonary embolism when administered in conjunction with warfarin sodium. (rxlist.com)
  • Fass environmental information for Innohep (tinzaparin) from LEO Pharma (downloaded 2012-06-17). (janusinfo.se)
  • Be sure to mention any of the following: dalteparin (Fragmin), enoxaparin (Lovenox), heparin, or tinzaparin (Innohep). (medlineplus.gov)
  • Objectives: The objective of the RIETECAT study was to compare the long-term effectiveness and safety of enoxaparin versus dalteparin or tinzaparin for the secondary prevention of VTE in adults with active cancer. (rsu.lv)
  • Methods: We used the data from the multicenter, multinational RIETE registry to compare the rates of VTE recurrences, major bleeding, or death over 6 months in patients with active cancer and acute VTE using full doses of enoxaparin versus dalteparin or tinzaparin, and a multivariable Cox proportional hazard model was used to analyze the primary end point. (rsu.lv)
  • There was limited difference in VTE recurrences (2.0% vs 2.5%) and mortality rate (19% vs 17%) between the enoxaparin and dalteparin or tinzaparin subgroups. (rsu.lv)
  • Conclusions: In RIETECAT, in patients with cancer and VTE receiving full-dose enoxaparin or dalteparin or tinzaparin, no statistically significant differences were observed regarding effectiveness and safety outcomes over a 6-month period. (rsu.lv)
  • Agents derived from the use of heparin include enoxaparin, dalteparin, tinzaparin and fondaparinux. (selectbiosciences.com)
  • and dalteparin or tinzaparin, 925 (754 + 171) patients. (rsu.lv)
  • Tinzaparin is an antithrombotic drug in the heparin group. (wikipedia.org)
  • Tinzaparin sodium is the sodium salt of a low molecular weight heparin obtained by controlled enzymatic depolymerization of heparin from porcine intestinal mucosa using heparinase from Flavobacterium heparinum . (rxlist.com)
  • Low molecular weight heparin (LMWH), the guideline based drug for prophylaxis and treatment of cancer-associated thrombosis, was recently shown to sensitize cisplatin resistant A2780cis human ovarian cancer cells for cisplatin cytotoxicity upon 24 h pretreatment with 50 μg × mL -1 of the LMWH tinzaparin in vitro , equivalent to a therapeutic dosage. (oncotarget.com)
  • No LMWH, except tinzaparin, is licensed for use in gestational hypercoagulability. (wikipedia.org)
  • Still, tinzaparin is often the LMWH of choice in pregnant women. (wikipedia.org)
  • Tinzaparin sodium is a polysulphated and acetylated glucosaminoglycane sodium salt (carbohydrate). (janusinfo.se)
  • After a normal chest x-ray, tinzaparin was administered empirically for possible occult pulmonary embolus. (gla.ac.uk)
  • In July 2008, the company revised the prescribing information to restrict the use of tinzaparin in patients 90 years of age or older. (wikipedia.org)
  • Anticoagulation with Tinzaparin in COVID-19 patients in ICU: are low anti-Xa levels associated with the development of trombo-embolic events? (vub.be)
  • Treatment of superficial vein thrombosis with intermediate does of tinzaparin. (europeanvenousforum.org)
  • Over the past 60 years, due to the advancement of hemo- the Work Group and tasked it with planning, developing, dialysis (HD) technology and the introduction of medical reviewing, and disseminating appropriate HD treatment insurance, dialysis treatment has become widespread, en- guidelines in accordance with international standards. (bvsalud.org)
  • Each 2 mL vial contains 20,000 anti-Factor Xa IU (anti-Xa) of tinzaparin sodium per mL, for a total of 40,000 IU, and 3.1 mg/mL sodium metabisulfite as a stabilizer. (nih.gov)
  • The mean tinzaparin sodium anti-factor Xa activity is approximately 100 IU per milligram. (nih.gov)
  • Bleeding time is usually unaffected by tinzaparin sodium. (nih.gov)
  • Activated partial thromboplastin time (aPTT) is prolonged by therapeutic doses of tinzaparin sodium used in the treatment of deep vein thrombosis (DVT). (nih.gov)
  • Prothrombin time (PT) may be slightly prolonged with tinzaparin sodium treatment but usually remains within the normal range. (nih.gov)
  • Neither aPTT nor PT can be used for therapeutic monitoring of tinzaparin sodium. (nih.gov)
  • Tinzaparin sodium induces release of tissue factor pathway inhibitor, which may contribute to the antithrombotic effect. (nih.gov)
  • Anti-Xa and anti-IIa activities are the primary biomarkers for assessing tinzaparin sodium exposure because plasma concentrations of low molecular weight heparins cannot be measured directly. (nih.gov)
  • Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study. (nih.gov)
  • Thromboprophylaxis following caesarean section--a comparison of the antithrombotic properties of three low molecular weight heparins--dalteparin, enoxaparin and tinzaparin. (nih.gov)
  • Dalteparin, enoxaparin and tinzaparin are licensed for the treatment of DVT. (bmj.com)
  • Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial. (stoptheclot.org)
  • Although tinzaparin has not been studied, other low molecular weight heparins (e.g., dalteparin, enoxaparin) are not excreted into breastmilk in clinically relevant amounts. (nih.gov)
  • Received Low Molecular Weight heparins (such as Dalteparin, Enoxaparin, Tinzaparin) in full dose within the previous 24 hours 20. (nih.gov)
  • Protamine sulfate will reverse tinzaparin by 85% per package insert. (wikipedia.org)
  • We observed tinzaparin dosing, frequency of anti Xa levels, dose changes, and pregnancy outcomes. (bmj.com)
  • Discussion All our patients received a higher tinzaparin dose than suggested by RCOG guidelines, but shown by anti-Xa monitoring to be therapeutic. (bmj.com)
  • Tinzaparin does not affect the international normalized ratio (INR), prothrombin time (PT). (wikipedia.org)
  • 9 June 2006 [review June 2009] (22)ESHRE April-2011 volume 33 pages 12-13-14 e-medicine 2011 RCOG March-2010 (Royal college for Obestetric and Gynecology) DVT.org/cardiologist Hull, New England Journal of Medicine, 2010 volume 22 page 19 tinzaparin at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Sprigg N, Gray LJ, Bath PM, et al. (wikipedia.org)
  • citation needed] Anti-factor Xa levels can be measured, and are often used to monitor tinzaparin. (wikipedia.org)